Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pallidotomy for severe Parkinson's disease dyskinesia and other motor features in a resource-limited setting: the Philippine experience and review of the literature.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Same author

Creutzfeldt-Jakob disease in the Philippines: diagnostic and management challenges from the first multicenter registry.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Same author

Challenges in the diagnosis and management of functional movement disorders in a developing nation: insights from the Philippines.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Same author

A multimodal biomarker strategy to enhance diagnostic precision in neurodegenerative parkinsonism.

Nature medicine·2026

Same author

Addressing Care Partner Burden from the Underrecognition of Iatrogenic Sexual Behavior Changes in Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026

Same author

Correction: Revisiting Parkinson's disease definition and classification: insights from two emerging biological frameworks.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Search research articles

Related Experiment Video

Updated: Dec 23, 2025

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

Levodopa challenge test: indications, protocol, and guide.

Gerard Saranza¹, Anthony E Lang^2,3,4

¹Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, Toronto, ON, Canada.

Journal of Neurology

|April 26, 2020

Summary

This summary is machine-generated.

The levodopa challenge test (LCT) is a safe Parkinson's disease evaluation tool. It guides treatment adjustments and surgical planning for improved patient management.

Keywords:

DBS screening Levodopa challenge test Levodopa responsiveness Levodopa unresponsiveness Parkinson's disease Short-duration response

More Related Videos

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

Related Experiment Videos

Last Updated: Dec 23, 2025

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

Area of Science:

Neurology
Clinical Pharmacology

Background:

The levodopa challenge test (LCT) is a widely used clinical procedure in Parkinson's disease (PD) management.
It offers valuable insights for various patient care aspects, including surgical readiness and medication optimization.

Purpose of the Study:

To review the indications and protocols for acute levodopa challenge tests in Parkinson's disease.
To discuss potential complications and levodopa response patterns.

Main Methods:

Review of existing literature on levodopa challenge test protocols and applications.
Analysis of data regarding patient management decisions based on LCT outcomes.

Main Results:

The LCT is instrumental in preoperative assessment for deep brain stimulation (DBS).
Test results inform medication adjustments for motor fluctuations and dyskinesias.
Understanding levodopa responsiveness is crucial for effective PD treatment.

Conclusions:

The levodopa challenge test is a valuable, safe, and versatile tool in clinical practice for Parkinson's disease.
It significantly impacts therapeutic strategies, from medication adjustments to surgical interventions.